Warsaw 2013 Programme Registration Exhibition Hotels Virtual Exhibition Warsaw Satellite Meetings Visa Information

Multifocal toric intraocular lens implantation as a solution for improving patients visual acuity and quality of life

Poster Details

First Author: E.Mrukwa-Kominek POLAND

Co Author(s):    L. Cwalina   K. Buczak Gasinska   A. Malec   P. Stala     

Abstract Details


The aim of the study was the assessment of the astigmatism correction’s results, changes in the activities of everyday life and satisfaction with vision in patients with privious corneal astigmatism after bilateral cataract surgery followed by posterior chamber implantation of multifocal toric intraocular lenses M-FLEX T (Rayner, UK)


: Departament of Ophthalmology, Medical University of Silesia, University Hospital No5, Katowice, Poland


The analysed material consisted of 26 eyes in 13 patients, mean age 56.8, enrolled for cataract surgery with multifocal toric IOL implantation M-FLEX T (Rayner, UK). The patients corneal astigmatism was higher than 1,5D, the addition for near vision was +4,0D. The follow up time was 12-24 months. Functional results and clinical state of the operated eyes during entire postoperative period was evaluated. We compared: pre- and postoperative UCDVA, BCDVA, UCNVA, changes of the postoperative objective refraction, contrast sensitivity and patients subjective satisfaction.


No statistically significant difference in pre- and postoperative corneal astigmatism was reported. Before surgery the mean UCDVA was 0,33±0,11, the mean BCDVA was 0,61 ±0,091. Post-op mean UCDVA was 0.99, UCNVA was J2 in 85% of eyes. The intermediate vision was satisfied in 91% of eyes. There is no coincidence between changes of the distance visual acuity and measures of the quality of life with the VF-14 index.


The greatest advantage of the multifocal toric M-FLEX T IOL implantation is that it can provide good uncorrected distance and near visual acuities reducing the dependence on spectacles. Procedure is reasonable refractive surgery option for middle-aged patients.

Financial Disclosure:

... receives non-monetary benefits from a competing company.

Back to previous